Strategies for Novel Therapeutic Approaches Targeting Cytokines and Signaling Pathways of Osteoclasto- and Osteoblastogenesis in the Fight Against Immune-Mediated Bone and Joint Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|2|127-136

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.2, 2008-01, pp. : 127-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis

By Jules Joel   Ashley Jason W   Feng Xu  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 9, 2010-09 ,pp. : 923-934

Informa Healthcare

Access to resources Recommend Favorite

Targeting Toll-Like Receptor Signaling Pathways for Design of Novel Immune Therapeutics

By  

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 29-38

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models of Central Nervous System Immune-Mediated Diseases: Therapeutic Interventions with Bioactive Peptides and Mimetics

By  

Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. : 1513-1519

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Interleukin-21 in Immune-Mediated Pathologies

By  

Current Drug Targets, Vol. 11, Iss. 5, 2010-05 ,pp. : 645-649

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-01 ,pp. : 487-496

Bentham Science Publishers

Access to resources Recommend Favorite